HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The impact of 5,10-methenyltetrahydrofolate synthetase polymorphism on diabetic nephropathy in the Taiwanese population.

Abstract
Genome-wide association studies provide information implicating 5,10-methenyltetrahydrofolate synthetase (MTHFS) as a candidate gene for renal disease. In the Atherosclerosis Risk in Communities study, the intronic single-nucleotide polymorphism rs6495446 in the gene MTHFS confirmed the association between this gene and renal disease among Caucasian participants. We replicated this genetic association in a Taiwanese population with diabetic nephropathy (DN). A total of 358 Taiwanese patients with type 2 diabetes (T2D) were recruited. The case group comprised 180 T2D patients with DN, and the control group comprised the remaining patients without DN. rs6495446 in MTHFS had no significant effect on the risk of DN in Taiwanese patients with T2D. Multivariate logistic regression analysis demonstrated that being male, the duration of diabetes, plasma triglyceride level, and glycemic control were factors that predicted the development of DN.
AuthorsChin-Jung Lin, Min-Jie Wen, Yi-Jen Hung, Dee Pei, Shi-Wen Kuo, Chang-Hsun Hsieh
JournalGenetic testing and molecular biomarkers (Genet Test Mol Biomarkers) Vol. 16 Issue 2 Pg. 142-5 (Feb 2012) ISSN: 1945-0257 [Electronic] United States
PMID21895484 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carbon-Nitrogen Ligases
  • 5,10-methenyltetrahydrofolate synthetase
Topics
  • Aged
  • Asian People (genetics)
  • Carbon-Nitrogen Ligases (genetics)
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 (complications, genetics)
  • Diabetic Nephropathies (genetics)
  • Female
  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • Genotype
  • Humans
  • Introns (genetics)
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide (genetics)
  • Taiwan

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: